TMED4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.118200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.566180E-01
Normal-vs-Stage2
3.468000E-01
Normal-vs-Stage3
5.781400E-01
Normal-vs-Stage4
3.626400E-01
Stage1-vs-Stage2
2.748000E-01
Stage1-vs-Stage3
1.244410E-01
Stage1-vs-Stage4
5.649800E-01
Stage2-vs-Stage3
1.078250E-01
Stage2-vs-Stage4
3.596600E-01
Stage3-vs-Stage4
2.089800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.145000E-01
Normal-vs-AfricanAmerican
1.655570E-01
Normal-vs-Asian
6.430200E-01
Caucasian-vs-AfricanAmerican
7.854800E-01
Caucasian-vs-Asian
4.551000E-01
AfricanAmerican-vs-Asian
3.983200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.197400E-01
Normal-vs-Female
4.052400E-01
Male-vs-Female
4.660200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.327400E-01
Normal-vs-Age(41-60Yrs)
1.958380E-01
Normal-vs-Age(61-80Yrs)
5.306600E-01
Normal-vs-Age(81-100Yrs)
7.090000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.940400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.020400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.643600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.153800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.768000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.084600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.450200E-01
Normal-vs-Daily Drinker
4.270400E-01
Normal-vs-Weekly Drinker
7.011200E-01
Normal-vs-Occasional Drinker
2.139600E-01
Normal-vs-Social Drinker
3.708600E-01
Non Drinker-vs-Daily Drinker
7.515400E-01
Non Drinker-vs-Weekly Drinker
5.983600E-01
Non Drinker-vs-Occasional Drinker
5.617800E-02
Non Drinker-vs-Social Drinker
2.586800E-01
Daily Drinker-vs-Weekly Drinker
4.182600E-01
Daily Drinker-vs-Occasional Drinker
8.985700E-02
Daily Drinker-vs-Social Drinker
3.936600E-01
Weekly Drinker-vs-Occasional Drinker
2.942300E-02
Weekly Drinker-vs-Social Drinker
1.927620E-01
Occasional Drinker-vs-Social Drinker
4.517400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.601000E-01
Normal-vs-Grade 2
9.943400E-03
Normal-vs-Grade 3
3.143600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.446250E-01
Grade 1-vs-Grade 3
5.292800E-01
Grade 1-vs-Grade 4
2.601000E-01
Grade 2-vs-Grade 3
3.429800E-02
Grade 2-vs-Grade 4
9.943400E-03
Grade 3-vs-Grade 4
3.143600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.824600E-01
Normal-vs-NonDiabetic
3.901800E-01
Diabetic-vs-NonDiabetic
1.493370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.546850E-01
Normal-vs-NoPancreatitis
4.281800E-01
Pancreatitis-vs-NoPancreatitis
9.837000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.847600E-01
Normal-vs-N1
3.520600E-01
N0-vs-N1
4.414600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.442410E-01
Normal-vs-TP53-NonMutant
5.515400E-03
TP53-Mutant-vs-TP53-NonMutant
3.530800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
